| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.26 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.009 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |